Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Serial] Front line of DDS development in pharmaceutical industries
Topical Onychomycosis Treatment Product Clenafin® Topical Solution 10%
Ryoichi Sonoda
Author information
JOURNAL FREE ACCESS

2017 Volume 32 Issue 1 Pages 60-64

Details
Abstract

CLENAFIN® topical solution 10% is the country’s first topical treatment for onychomycosis, launched in Japan in September 2014. CLENAFIN® contains efinaconazole, novel triazole antifungal drug as its active ingredient. Efinaconazole does not bind well with keratin, the main component of nails, meaning that this drug has superior nail penetrating properties. CLENAFIN® has proven effective in treating onychomycosis through once-daily application to the infected nails. CLENAFIN® comes packaged in a bottle with a connected brush, making it easy to apply the drug across the surface of nails.

Content from these authors
© 2017 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top